XML 76 R60.htm IDEA: XBRL DOCUMENT v3.25.0.1
Debt Textual (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Apr. 17, 2023
USD ($)
Dec. 07, 2020
USD ($)
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Jul. 29, 2022
USD ($)
Debt Instrument [Line Items]                    
Net proceeds from secured term loans             $ 0 $ 300,000,000 $ 73,072,000  
Gain (loss) on extinguishment of debt             0 29,019,000 0  
Pharmakon Advisors, LP                    
Debt Instrument [Line Items]                    
Capitalized interest rate 0.50                  
Pharmakon Advisors, LP | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate                    
Debt Instrument [Line Items]                    
Variable rate floor 0.0175                  
Debt instrument, basis spread on variable rate 7.00%                  
Pharmakon Advisors, LP | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | PIK Interest Payment is Made                    
Debt Instrument [Line Items]                    
Debt instrument, basis spread on variable rate 7.25%                  
Pharmakon Advisors, LP | Line of Credit                    
Debt Instrument [Line Items]                    
Periodic payment             $ 25,000,000      
Debt instrument, prepayment fee, percentage of principal voluntary payments             3.00%      
Pharmakon Advisors, LP | Line of Credit | Between the Second and Third Anniversaries                    
Debt Instrument [Line Items]                    
Debt instrument, prepayment fee, percentage of principal voluntary payments             3.00%      
Pharmakon Advisors, LP | Line of Credit | After Third Anniversary                    
Debt Instrument [Line Items]                    
Debt instrument, prepayment fee, percentage of principal voluntary payments             2.00%      
Pharmakon Advisors, LP | Line of Credit | After Fourth Anniversary                    
Debt Instrument [Line Items]                    
Debt instrument, prepayment fee, percentage of principal voluntary payments             1.00%      
Athyrium | Senior Credit Facility                    
Debt Instrument [Line Items]                    
Repayments of lines of credit $ 241,787,000                  
MidCap Financial Services, LLC | Senior Credit Facility                    
Debt Instrument [Line Items]                    
Repayments of lines of credit   $ 43,298,000                
Loan Agreement | Pharmakon Advisors, LP                    
Debt Instrument [Line Items]                    
Debt instrument, face amount 450,000,000                  
Net proceeds from secured term loans 25,805,000                  
Term Loan Tranche A | Pharmakon Advisors, LP | Line of Credit                    
Debt Instrument [Line Items]                    
Debt instrument, face amount $ 300,000,000                  
Net proceeds from secured term loans             $ 300,000,000 $ 300,000,000    
Effective interest rate             13.14% 13.30%    
Interest expense, debt, total             $ 39,874,000 $ 27,326,000    
Periodic payment, interest           $ 10,041,000 29,833,000 13,663,000    
Fair value disclosure             323,704,000 313,663,000    
Debt instrument, unamortized discount (premium) and debt issuance costs, net, total             11,147,000      
Amortization of debt issuance costs             $ 1,597,000 $ 715,000    
Debt instrument, term (month) 18 months                  
Term Loan Tranche A | Pharmakon Advisors, LP | Line of Credit | PIK Interest Payment is Made                    
Debt Instrument [Line Items]                    
Percent of interest payment     0.50 0.50 0.50     0.50    
Term Loan Tranche B | Pharmakon Advisors, LP | Line of Credit                    
Debt Instrument [Line Items]                    
Debt instrument, face amount $ 50,000,000                  
Term Loan Tranche C | Pharmakon Advisors, LP | Line of Credit                    
Debt Instrument [Line Items]                    
Debt instrument, face amount 50,000,000                  
Term Loan Tranche D | Pharmakon Advisors, LP | Line of Credit                    
Debt Instrument [Line Items]                    
Debt instrument, face amount 50,000,000                  
Credit Agreement | Athyrium                    
Debt Instrument [Line Items]                    
Debt instrument, face amount   $ 200,000,000                
Debt instrument, LIBOR floor   1.75%                
Debt instrument, LIBOR cap   3.50%                
Debt instrument, exit fee, percentage of principal   2.00%                
Debt instrument, commitment fee percentage   1.00%                
Paid-in-kind interest               $ 8,476,000 23,387,000  
Long-term debt, total 240,452,000                  
Interest expense, long-term debt $ 1,335,000                  
Debt instrument, term (month) 17 days                  
Debt instrument, fee amount $ 17,261,000                  
Debt issuance costs, net, total 11,758,000                  
Gain (loss) on extinguishment of debt $ 29,019,000                  
Credit Agreement | Athyrium | London Interbank Offered Rate (LIBOR)                    
Debt Instrument [Line Items]                    
Debt instrument, basis spread on variable rate   8.25%                
Credit Agreement | Athyrium | London Interbank Offered Rate (LIBOR) | PIK Interest Payment is Made                    
Debt Instrument [Line Items]                    
Debt instrument, basis spread on variable rate   10.25%                
Credit Agreement | Athyrium | Term A Loan                    
Debt Instrument [Line Items]                    
Net proceeds from secured term loans   $ 125,000,000                
Amortization of debt issuance costs               $ 1,069,000 $ 916,000  
Credit Agreement | Athyrium | Term B Loan                    
Debt Instrument [Line Items]                    
Debt instrument, face amount                   $ 25,000,000
Credit Agreement | Athyrium | Term C Loan                    
Debt Instrument [Line Items]                    
Debt instrument, face amount                   50,000,000
Credit Agreement | Athyrium | Term B And C Loan                    
Debt Instrument [Line Items]                    
Debt instrument, face amount                   75,000,000
Deferred debt fees and issuance costs                   $ 3,428,000
Credit Agreement | Athyrium | Term Loans                    
Debt Instrument [Line Items]                    
Effective interest rate               13.71% 12.87%